<p>NeueHealth, Inc.（纽约证券交易所代码：NEUE - 获取免费报告）董事 Anthony Jr. Florence 于 10 月 2 日星期四出售了 4,195 股该股票。股票的平均售价为 6.75 美元，总交易额为 28,316.25 美元。交易后，该董事在公司持有 488,702 股，估值约为 3,298,738.50 美元。此次交易代表其持股减少了 0.85%。该出售在向证券交易委员会的法律文件中披露，相关信息可通过此链接获取。</p>
<h2>NeueHealth 股票表现</h2>
<p>在周一的午盘交易中，NeueHealth 股票保持在 6.75 美元不变。NeueHealth, Inc.的十二个月最低价为 3.79 美元，最高价为 7.66 美元。该公司的 50 日简单移动平均线为 6.72 美元，200 日简单移动平均线也为 6.72 美元。该公司的市值为 6094 万美元，市盈率为-0.42，贝塔值为 0.59。</p>
<p>NeueHealth（纽约证券交易所代码：NEUE - 获取免费报告）最近在 8 月 7 日星期四发布了季度财报。该公司报告本季度每股收益（EPS）为-1.68 美元，超出分析师一致预期的-4.77 美元，差额为 3.09 美元。该季度的收入为 2.0908 亿美元，而分析师预期为 2.495 亿美元。分析师平均预测 NeueHealth, Inc.在本财年将发布每股收益-9.13 美元。</p>
<h2>机构资金流入和流出</h2>
<p>一家对冲基金最近在 NeueHealth 股票中购买了新股份。根据该公司在最近向证券交易委员会提交的 13F 表格，PenderFund Capital Management Ltd.在第一季度购买了 NeueHealth, Inc.（纽约证券交易所代码：NEUE - 免费报告）的新股份。该基金购买了 29,115 股公司股票，估值约为 197,000 美元。PenderFund Capital Management Ltd.在最近的报告期末持有 NeueHealth 的 0.33%。对冲基金和其他机构投资者持有该公司 63.88% 的股票。</p>
<h2>分析师评级上调和下调</h2>
<p>另外，Weiss Ratings 在 9 月 27 日星期六的报告中重申了对 NeueHealth 股票的 “卖出（e+）” 评级。一位分析师对该股票给予了持有评级，另一位则给予了卖出评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “减持”，共识目标价为 7.00 美元。</p>
<p><strong>获取我们对 NEUE 的最新分析</strong></p>
<h2>关于 NeueHealth</h2>
<p>（获取免费报告）</p>
<p>NeueHealth, Inc.是一家医疗保健公司，为美国的健康消费者、提供者和支付方提供各种医疗服务。它通过两个部门运营：NeueCare 和 NeueSolutions。NeueCare 部门通过自有和附属诊所向 ACA 市场、医疗保险和医疗补助提供医疗服务。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票比 NeueHealth 更好</li>
<li>什么是低市盈率，它对投资者意味着什么？</li>
<li>3 只卓越股票以建立长期财富</li>
<li>零售股票投资，详解</li>
<li>Broadcom 和 CoreWeave 的内部销售激增：前景警示？</li>
<li>标普 500 股票对投资者市场的启示是什么？</li>
<li>Marvell 内部人士购买股票——投资者应该跟随吗？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU5FVUU?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU5FVUU"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 NeueHealth 吗？</h2>
<p>在考虑 NeueHealth 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 NeueHealth 并不在名单上。</p>
<p>虽然 NeueHealth 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

NEUE

<p>NeueHealth, Inc.（纽约证券交易所代码：NEUE）的董事 Anthony Jr. Florence 于 10 月 2 日以每股 6.75 美元的价格出售了 4,195 股，总计 28,316.25 美元。出售后，他持有 488,702 股，价值约 330 万美元，反映出其持股减少了 0.85%。该股票在交易中保持平稳，价格为 6.75 美元。分析师对该股票的共识评级为 “减持”，目标价为 7.00 美元。机构投资者持有 NeueHealth 63.88% 的股份，该公司报告的季度每股收益为（1.68 美元），超出预期</p>

<p>NeueHealth, Inc. (NYSE:NEUE - Get Free Report) Director Anthony Jr. Florence sold 4,195 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $6.75, for a total transaction of $28,316.25. Following the transaction, the director owned 488,702 shares in the company, valued at approximately $3,298,738.50. This trade represents a 0.85% decrease in their position. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through this link.</p>
<div class="lb-trans"><p>NeueHealth, Inc.（纽约证券交易所代码：NEUE - 获取免费报告）董事 Anthony Jr. Florence 于 10 月 2 日星期四出售了 4,195 股该股票。股票的平均售价为 6.75 美元，总交易额为 28,316.25 美元。交易后，该董事在公司持有 488,702 股，估值约为 3,298,738.50 美元。此次交易代表其持股减少了 0.85%。该出售在向证券交易委员会的法律文件中披露，相关信息可通过此链接获取。</p>
</div><h2>NeueHealth Stock Performance</h2>
<div class="lb-trans"><h2>NeueHealth 股票表现</h2>
</div><p>NeueHealth stock remained flat at $6.75 during mid-day trading on Monday. NeueHealth, Inc. has a twelve month low of $3.79 and a twelve month high of $7.66. The company has a fifty day simple moving average of $6.72 and a two-hundred day simple moving average of $6.72. The firm has a market capitalization of $60.94 million, a PE ratio of -0.42 and a beta of 0.59.</p>
<div class="lb-trans"><p>在周一的午盘交易中，NeueHealth 股票保持在 6.75 美元不变。NeueHealth, Inc.的十二个月最低价为 3.79 美元，最高价为 7.66 美元。该公司的 50 日简单移动平均线为 6.72 美元，200 日简单移动平均线也为 6.72 美元。该公司的市值为 6094 万美元，市盈率为-0.42，贝塔值为 0.59。</p>
</div><p>NeueHealth (NYSE:NEUE - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported ($1.68) EPS for the quarter, beating analysts' consensus estimates of ($4.77) by $3.09. The company had revenue of $209.08 million for the quarter, compared to analyst estimates of $249.50 million. On average, analysts forecast that NeueHealth, Inc. will post -9.13 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>NeueHealth（纽约证券交易所代码：NEUE - 获取免费报告）最近在 8 月 7 日星期四发布了季度财报。该公司报告本季度每股收益（EPS）为-1.68 美元，超出分析师一致预期的-4.77 美元，差额为 3.09 美元。该季度的收入为 2.0908 亿美元，而分析师预期为 2.495 亿美元。分析师平均预测 NeueHealth, Inc.在本财年将发布每股收益-9.13 美元。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A hedge fund recently bought a new stake in NeueHealth stock. PenderFund Capital Management Ltd. purchased a new stake in NeueHealth, Inc. (NYSE:NEUE - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 29,115 shares of the company's stock, valued at approximately $197,000. PenderFund Capital Management Ltd. owned 0.33% of NeueHealth at the end of the most recent reporting period. Hedge funds and other institutional investors own 63.88% of the company's stock.</p>
<div class="lb-trans"><p>一家对冲基金最近在 NeueHealth 股票中购买了新股份。根据该公司在最近向证券交易委员会提交的 13F 表格，PenderFund Capital Management Ltd.在第一季度购买了 NeueHealth, Inc.（纽约证券交易所代码：NEUE - 免费报告）的新股份。该基金购买了 29,115 股公司股票，估值约为 197,000 美元。PenderFund Capital Management Ltd.在最近的报告期末持有 NeueHealth 的 0.33%。对冲基金和其他机构投资者持有该公司 63.88% 的股票。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级上调和下调</h2>
</div><p>Separately, Weiss Ratings reiterated a &#34;sell (e+)&#34; rating on shares of NeueHealth in a report on Saturday, September 27th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of &#34;Reduce&#34; and a consensus price target of $7.00.</p>
<div class="lb-trans"><p>另外，Weiss Ratings 在 9 月 27 日星期六的报告中重申了对 NeueHealth 股票的 “卖出（e+）” 评级。一位分析师对该股票给予了持有评级，另一位则给予了卖出评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “减持”，共识目标价为 7.00 美元。</p>
</div><p><strong>Get Our Latest Analysis on NEUE</strong></p>
<div class="lb-trans"><p><strong>获取我们对 NEUE 的最新分析</strong></p>
</div><h2>About NeueHealth</h2>
<div class="lb-trans"><h2>关于 NeueHealth</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.</p>
<div class="lb-trans"><p>NeueHealth, Inc.是一家医疗保健公司，为美国的健康消费者、提供者和支付方提供各种医疗服务。它通过两个部门运营：NeueCare 和 NeueSolutions。NeueCare 部门通过自有和附属诊所向 ACA 市场、医疗保险和医疗补助提供医疗服务。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than NeueHealth</li>
<li>What is a Low P/E Ratio and What Does it Tell Investors?</li>
<li>3 Exceptional Stocks to Build Long-Term Wealth</li>
<li>Retail Stocks Investing, Explained</li>
<li>Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?</li>
<li>What Do S&amp;P 500 Stocks Tell Investors About the Market?</li>
<li>Marvell Insiders Buy Shares—Should Investors Follow Suit?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票比 NeueHealth 更好</li>
<li>什么是低市盈率，它对投资者意味着什么？</li>
<li>3 只卓越股票以建立长期财富</li>
<li>零售股票投资，详解</li>
<li>Broadcom 和 CoreWeave 的内部销售激增：前景警示？</li>
<li>标普 500 股票对投资者市场的启示是什么？</li>
<li>Marvell 内部人士购买股票——投资者应该跟随吗？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU5FVUU" alt="" original-src="https://www.marketbeat.com/scripts/InsiderTradesChart.ashx?Prefix=NYSE&amp;Symbol=NEUE"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in NeueHealth Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 NeueHealth 吗？</h2>
</div><p>Before you consider NeueHealth, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 NeueHealth 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NeueHealth wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 NeueHealth 并不在名单上。</p>
</div><p>While NeueHealth currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 NeueHealth 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Anthony Jr. Florence 出售了 4,195 股 NeueHealth (NYSE:NEUE) 的股票